Tradestie Institutional Equity Comparison Engine
CAMP vs SLS โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
SLS Overall Edge
SLS Captures Institutional Edge (3โ0 Pillars ยท 4โ3 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to SELLAS Life Sciences Group, Inc. Common Stock (SLS) driven by superior Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, CAMP trades at N/M Forward P/E with -991.8% operating margin (+138.9% YoY revenue) versus SLS at N/M Forward P/E and 0.0% operating margin (-82.5% YoY). In options structure, CAMP sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against SLS sits in BREAKOUT (74th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
CAMP N/M vs SLS N/M Fwd P/E
Growth & Margin Winner
SLS
Op Margin -991.8% vs 0.0% ยท YoY +138.9% vs -82.5%
Momentum & Technical Winner
SLS
1Y -2.4% vs +1239.2% ยท 52W Pos 23% vs 76%
Options & Structure Winner
SLS
UNCLASSIFIED (N/A IV) vs BREAKOUT (74th %ile IV)
CAMP
NASDAQ
CAMP4 Therapeutics Corporation Common Stock
Pharmaceutical Preparations
$4.00
+3.63% 1D
Market Cap
$238.5M
1M Return
+27.39%
1Y Return
-2.44%
Forward P/E
N/M
Unified AI Score
43.9 / 100
HOLD
Tech 34.0
Fund 40.0
Flow 50.0
Mom 40.0
SLS
NASDAQ
SELLAS Life Sciences Group, Inc. Common Stock
Pharmaceutical Preparations
$19.15
+156.36% 1D
Market Cap
$1.6B
1M Return
+82.55%
1Y Return
+1239.16%
Forward P/E
N/M
Unified AI Score
34.1 / 100
SELL
Tech 5.0
Fund 37.0
Flow 66.0
Mom 38.9
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
CAMP -2.44%
SLS +1239.16%
Spread: +1241.6 pp (SLS Lead)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | CAMP Revenue | SLS Revenue | CAMP Op. Margin | SLS Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2013 | N/A | $0M | N/A | -1145.5% | SLS |
| FY2014 | N/A | $10M | N/A | -471.1% | SLS |
| FY2020 | N/A | $0M | N/A | -893.8% | SLS |
| FY2021 | N/A | $10M | N/A | -332.8% | SLS |
| FY2022 | N/A | $0M | N/A | -4195.0% | SLS |
| FY2023 | $0M | N/A | -14822.6% | N/A | CAMP |
| FY2024 | $0M | N/A | -8142.3% | N/A | CAMP |
| FY2025 | $0M | N/A | -1502.4% | N/A | CAMP |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | CAMP | SLS | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $238.5M | $1.6B | Larger Scale | SLS |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +138.9% | -82.5% | Higher Growth | CAMP |
| Operating Margin (TTM) Profitability | -991.8% | 0.0% | Higher Margin | SLS |
| Net Profit Margin Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | -146.1% | -40.3% | Higher ROE | SLS |
| 52-Week Range Position Momentum | 23% ($3โ$8) | 76% ($1โ$25) | Stronger Trend | SLS |
| Beta / 30D Volatility Risk Regime | 1.35ฮฒ ยท 94% Vol | 1.38ฮฒ ยท 568% Vol | Lower Realized Risk | CAMP |
| Unified Institutional Score Composite Signal | 43.9 / 100 (HOLD) | 34.1 / 100 (SELL) | Higher Composite | CAMP |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full CAMP vs SLS Buy Guide
CAMP
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
SLS
BREAKOUT
99d in phase ยท OBV ACCUMULATION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
74th %ile
IV Regime
Elevated (60thโ80th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither CAMP nor SLS registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.